Pharmaceutical Product Peptides Powder Cagrilintide Retatrutide Semax Mots-C HMG
TDS 8 Inquiries
61489-71-2
Research Grade
99%
GUANGZHOU
HF
75iu
Yes
2026-11-14
peptides
-
Product Description
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceExtracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.CertificatesBasic Info
-
Product Name:
Menotropin
Other Name:Gonadotropin,menopausal;Menopausal gonadotropin;Pergonal;Humegon;Human menopausal gonadotropin;Menotropin;Neopergonal;Homogonal;Pergovet;Normegon;Menotrophin;Humegon 100;Pergonal 75;Pergonal 150;Lepori;Menogon;Merional;Repronex;Menopur;Human menopausal gonadotrophin;Urogonadotropin;hMG Fuji;Ovugraf HP;Menogon HP;Menotropins
CAS No.:61489-71-2
InChIKeys:CBUWTGCATVNMJE-UHFFFAOYSA-N
Molecular Weight:142.23862
Exact Mass:142.13600
EC Number:612-157-8
ATC Code:G - Genito urinary system and sex hormones
Categories:
Characteristics-
PSA:
17.07000
XLogP3:2.79180
Water Solubility:SOL IN WATER, PHYSIOLOGICAL SALINE SOLN, 50% ALC, IN PH 4.4 ACETATE BUFFER OF 20.5% SODIUM SULFATE
Storage Conditions:2-8°C
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides
-
Location:
No. 85, Qingnian Road, Hongqiao District, Tianjin
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted
Australia
Retatrutide + Cagrilintide
10 MT Sep 20, 2026
United States
HMG 75iu
3 MT Aug 13, 2026
United States
HMG 75iu
3 MT Aug 13, 2026
United States
HMG
1 KG Dec 16, 2025
Brazil
Hmg
10 PCS Nov 2, 2025
Germany
human Menopausal Gonadotropin
20 MG Oct 9, 2025
Germany
human menopausal Gonadotropin (hMG)
50 PCS Oct 8, 2025
Germany
Labor für molekulare stoffwechselgenetik Dr. Podskarbi
50 PCS Oct 7, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Factory Supply High Purity Citric Acid Powder CAS 77-92-9 Raw Material For Lemon Bottle Body Contouring Fat Dissolving Cosmetic Formula
Pharma Grade / Research Grade / 99.9%
$19.21-24.02/G FOB
-
-
-
-
the best quality and most favorable price freeze-dried powder MGF peptide CAS:12020-86-9 99%
Research Grade / 99.9%
$20-25/G FOB
-
-
-
-
Global Manufacturer of 99% Purity KPV Peptide (CAS No. 67727-97-3)
Research Grade / 99.9%
$20.4-25.5/G FOB
-
-
-
-
Top Quality Weight Loss Raw Material Powder 99% SLU-PP-332 CAS 303760-60-3 SLUPP332
Research Grade / 99%
$20.4-25.5/G FOB
-
-
-
-
Custom Peptides Lyophilized Powder Retatrutide 10 Mg 20mg Weight Loss Peptide2381089-83-2
Research Grade / 99.9%
$20.4-25.5/G FOB
-
-
-
-
High Purity99% Peptide Ss-31 Selank Mt2 Dsip Epithalon Adipotide Semg Tir Semx Retatrutide Peptide
Research Grade / 99.9%
$20-25/G FOB
-
